Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LPO | P22079 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL4250215 | 0.88 | LPO (0.41) | CA12CA1CA2CA9LPO | |
| Sulfuric Acid SCHEMBL2995711 | 0.88 | LPO (0.41) | CA12CA1CA2CA9LPO | |
| SCHEMBL3000417 | 0.86 | CA12 (0.42) | CA12CA1CA2CA9LPO | |
| SCHEMBL3008710 | 0.83 | KMT2A (0.38) | CA12CA1CA2CA9LPO | |
| SCHEMBL3104611 | 0.80 | LPO (0.41) | RECQLCA12CA1CA2CA9 | |
| Trifluoromethanesulfonic Acid SCHEMBL1682013 | 0.80 | ALDH1A1 (0.37) | CA12CA1CA2CA9LPO | |
| Methyl Alcohol SCHEMBL28649922 | 0.80 | — | — | |
| SCHEMBL15149 | 0.79 | — | — | |
| SCHEMBL16694847 | 0.79 | — | — | |
| SCHEMBL22832317 | 0.79 | SMN1; SMN2 (0.42) | LPOSMN1; SMN2HTTBRD4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9587182-B2 | Synergistic formulations of functionalized copolymers and ionic liquids for dehydrated and desalted of medium, heavy and extra heavy crude oils | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2017-03-07 | — | — | US | claimed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| CN-111836849-B | Process for producing fibers, films and moldings of polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-3512905-B1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2022-08-24 | — | — | EP | disclosed |
| CN-109790292-B | Process for preparing polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2022-05-31 | — | — | CN | disclosed |
| US-20200407508-A1 | METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) | BASF SE (DE) | 2020-12-31 | — | — | US | disclosed |
| CN-111836849-A | Process for producing fibers, films and moldings of polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-104600352-B | Sodium rechargeable battery with the graphite felt for forming air vent channel | SK INNOVATION CO.,LTD. (KR) | 2019-11-01 | — | — | CN | disclosed |
| EP-3512905-A1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2019-07-24 | — | — | EP | disclosed |
| US-9650577-B2 | Synergistic formulations of functionalized copolymers and ionic liquids for dehydrated and desalted of medium, heavy and extra heavy crude oils | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2017-05-16 | — | — | US | disclosed |
| US-9587182-B2 | Synergistic formulations of functionalized copolymers and ionic liquids for dehydrated and desalted of medium, heavy and extra heavy crude oils | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2017-03-07 | — | — | US | disclosed |
| US-20150087729-A1 | SYNERGISTIC FORMULATIONS OF FUNCTIONALIZED COPOLYMERS AND IONIC LIQUIDS FOR DEHYDRATED AND DESALTED OF MEDIUM, HEAVY AND EXTRA HEAVY CRUDE OILS | MEXICANO INST PETROL (MX) | 2015-03-26 | — | — | US | disclosed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | disclosed |
| US-20120261312-A1 | SYNERGISTIC FORMULATIONS OF FUNCTIONALIZED COPOLYMERS AND IONIC LIQUIDS FOR DEHYDRATED AND DESALTED OF MEDIUM, HEAVY AND EXTRA HEAVY CRUDE OILS | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2012-10-18 | — | — | US | disclosed |
| US-7897806-B2 | Reacting primary amines with phosgene in ionic liquid as solvent | BASF AKTIENGESELLSCHAFT (DE) | 2011-03-01 | — | — | US | disclosed |
| US-20100191010-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | HUNTSMAN INTERNATIONAL LLC (US) | 2010-07-29 | — | — | US | disclosed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | disclosed |
| EP-2011782-A1 | Process for the synthesis of carbamates using co2 | HUNTSMAN INTERNATIONAL LLC (US) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | RECQL 2906/4885CA12 760/4885CA1 2478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.